Results 271 to 280 of about 698,290 (348)
Have gender and ethnic disparities in ophthalmology disappeared? Insights from a workforce-based study in Israel (2006–2021) [PDF]
Asaf Israeli +5 more
openalex +1 more source
Does Modified 5‐Item Frailty Index Correlate With Survival in Oropharyngeal Squamous Cell Carcinoma?
ABSTRACT Introduction Oropharyngeal squamous cell cancer (OPSCC) is a common subtype of head and neck cancer. It is generally stratified into high, intermediate, and low risk prognostic groups on the basis of HPV (human papillomavirus) status and smoking history (Ang risk stratification).
Marta Chmielecka +10 more
wiley +1 more source
Comment on: Ocular biometric parameters in South-Indian children with myopia. [PDF]
Choudhary D, Majumdar A, Tibrewal S.
europepmc +1 more source
A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis [PDF]
Haque, Reza +3 more
core +1 more source
ABSTRACT Background Endoscopic surgical approaches for nasopharyngeal malignancies, including recurrent nasopharyngeal carcinoma (rNPC) and nasopharyngeal salivary gland tumors (NSGT), have seen significant development over the last decades. Our groups have expanded the classification of nasopharyngeal endoscopic resections (NER) from type 1 to 3 to ...
Francesco Boaria +20 more
wiley +1 more source
Editorial: Reviews in: ophthalmology 2024. [PDF]
Panos GD, Deshmukh R.
europepmc +1 more source
ABSTRACT Background Transoral laser microsurgery is a well‐established treatment for early glottic cancer. However, managing patients with close/positive margins remains debated. This study analyzes the relationship between resection margins and oncologic outcomes.
Sae Hatomi +4 more
wiley +1 more source
ABSTRACT Background ASP‐1929 photoimmunotherapy—cetuximab conjugated to IRDye 700DX and red light (690 nm) for localized drug activation—results in rapid, selective cell killing. Methods This phase Ib/II open‐label study evaluated ASP‐1929 photoimmunotherapy plus pembrolizumab in patients with recurrent/metastatic HNSCC (≥ 1 accessible lesion, PD‐L1 ...
David M. Cognetti +17 more
wiley +1 more source

